Laboratory reagents
Original notice title
Poland – Various medicinal products – Dostawy odczynników laboratoryjnych do sekwencjonowania NGS przy użyciu aparatu Ilumina
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
40 / 100
Risk factors
No estimated contract value is provided, making it difficult to assess bid competitiveness and budget.
Structured data indicates EU funding, but XML notice states 'no-eu-funds'. This may affect contract terms or funding co...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im.Ks. B.Markiewicza
- Country
- Poland
- CPV
- 33696500 - Laboratory reagents +1 more
- Deadline
- Aug 07, 2026
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration 12 MONTH
- Supply of laboratory reagents for NGS sequencing using Illumina apparatus
- Successive deliveries over 12 months
Show full summary
Open tender for successive deliveries of laboratory reagents for NGS sequencing using Illumina apparatus, organized by Szpital Specjalistyczny w Brzozowie. One lot, 12-month contract, award based on price (60%) and delivery time (40%). No estimated value provided. Documents available via eZamowienia portal. Inconsistency regarding EU funding (structured data indicates EU-funded, XML notice says no EU funds). Place of performance: Brzozów, Poland.
Risks
No estimated contract value is provided, making it difficult to assess bid competitiveness and budget.
Structured data indicates EU funding, but XML notice states 'no-eu-funds'. This may affect contract terms or funding co...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Open procedure
- Contract awards based on price (60%) and delivery time (40%)
Administrative
- Electronic submission required
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Brzozów, POL
Website
Buyer profile
Identifier
0000007954
Activity
Health
Lots (1)
LOT-0001
Laboratory reagents
Supply of laboratory reagents for NGS sequencing using Illumina platform. Successive deliveries over 12 months. Detailed description in attachment 1 to SWZ.
Location
Duration
Category
Award Criteria
Deadline
Award details
cena-max 60 pkt
Termin dostawy odczynników-max 40 pkt
Additional CPV codes
Value note
Show original TED data
Original lot title
Odczynniki laboratoryjne
Original TED description
Przedmiotem zamówienia są sukcesywne dostawy odczynników laboratoryjnych. Szczegółowy opis przedmiotu zamówienia znajduje się w załączniku nr 1 do SWZ.
Procurement Details
- Publication date
- 05 Jul 2026
- Languages
- Polish
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 464503-2026
Documents (1)
Similar tenders
Spain – Laboratory reagents – Sistema Dinámico de Compra de suministro de reactivos, material fungible, patrones, pequeño equipamiento y otros para los laboratorios de NASERTIC
Bulgaria – Medical equipments, pharmaceuticals and personal care products – „Доставка на реактиви, китове, консумативи и др. за нуждите на проекти по процедура BG05SFPR001-3.004 „Подкрепа за развитие на проектна докторантура“ на Програма "Образование" 2021-2027 г.“
Bulgaria – Medical equipments, pharmaceuticals and personal care products – „Доставка на реактиви, китове, консумативи и др. за обезпечаване на проекти по Фонд „Наука“, "Научни изследвания" и докторанти“
Finland – Medical equipments – PCR- ja nukleiinihappodiagnostiikkaan soveltuvat laitteet ja reagenssit, tarvikkeet, kontrollit (DPS 2025-2029)
Bulgaria – Laboratory reagents – Динамична система за покупки на лабораторни консумативи и реактиви
Bulgaria – Laboratory reagents – „Доставка на лабораторни реактиви, консумативи и стъклария за нуждите на Пловдивски университет „ПАИСИЙ ХИЛЕНДАРСКИ“
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
40 / 100
Risk factors
No estimated contract value is provided, making it difficult to assess bid competitiveness and budget.
Structured data indicates EU funding, but XML notice states 'no-eu-funds'. This may affect contract terms or funding co...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications